GO:0004551 dinucleotide phosphatase activity: Mechanism, Genes and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0004551 (dinucleotide phosphatase activity) catalyzes the hydrolysis of a dinucleotide into two mononucleotides, and is synonymous with nucleotide pyrophosphatase and nucleotide diphosphatase activity.
The reaction is a fundamental nucleotide salvage and turnover step that feeds mononucleotides into purine and pyrimidine pools, which are tightly linked to cellular redox and energy metabolism.
Enzymes with this activity, such as ENPP1 and ENPP3, are ectoenzymes that also generate immunomodulatory nucleotides and are studied in cancer, inflammation, and metabolic disease.
Loss- or gain-of-function of dinucleotide phosphatase activity can alter NAD(H)/NADP(H) homeostasis, affecting immune cell function and tumor progression.
CRISPR knockout, point-mutation, knock-in, and overexpression models are essential to dissect the causal role of individual dinucleotide phosphatases in disease.
Targeted metabolomics, enzyme assays, and CRISPR library screening are the primary methods for discovering and validating dinucleotide phosphatase function.

Description

Dinucleotide phosphatase activity (GO:0004551) is a molecular function defined as the catalysis of the reaction: a dinucleotide + H2O = 2 mononucleotides. This activity is central to nucleotide metabolism because it converts dinucleotides into mononucleotides that can be reused for nucleic acid synthesis, energy transfer, and signaling. The term is synonymous with nucleotide pyrophosphatase and nucleotide diphosphatase activity, reflecting the hydrolytic cleavage of pyrophosphate or phosphodiester bonds in dinucleotide substrates. Researchers study this activity because it controls the balance of nucleotide pools that influence cell proliferation, immune responses, and metabolic adaptation. In recent years, the role of dinucleotide phosphatases has expanded beyond simple catabolism. For example, ectonucleotide pyrophosphatase/phosphodiesterase family members can hydrolyze extracellular nucleotides and thereby modulate purinergic signaling in immune cells. In parallel, intracellular enzymes with dinucleotide phosphatase activity contribute to the regulation of NAD(H) and NADP(H), which are critical cofactors for redox reactions and biosynthetic pathways. These functions link GO:0004551 to diverse physiological processes, including inflammation, tumorigenesis, and metabolic homeostasis. Understanding dinucleotide phosphatase activity at the molecular level requires integrating structural, biochemical, and genetic approaches. CRISPR-based models allow precise perturbation of genes encoding these enzymes, enabling researchers to test causality in disease models such as colorectal cancer and inflammatory disorders. This article summarizes the definition, mechanism, key genes, disease relevance, and research methods for GO:0004551, with an emphasis on publication-ready evidence from real literature.

dinucleotide phosphatase activity At A Glance

GO ID GO:0004551
GO term dinucleotide phosphatase activity
Ontology molecular_function
Synonym dinucleotide nucleotidohydrolase activity; nucleotide diphosphatase activity; nucleotide pyrophosphatase activity
Definition Catalysis of the reaction: a dinucleotide + H2O = 2 mononucleotides.
Major function Hydrolysis of dinucleotides to mononucleotides, contributing to nucleotide salvage and turnover.
Representative enzymes Ectonucleotide pyrophosphatase/phosphodiesterase family members (e.g., ENPP1, ENPP3) and other dinucleotide hydrolases.
Cellular context Cytosolic, membrane-bound, and extracellular enzymes; activity can influence purinergic signaling and redox balance.
Disease links Cancer, inflammation, metabolic disorders, and immune dysfunction.

What Is GO:0004551?

GO:0004551, dinucleotide phosphatase activity, is a molecular function that catalyzes the hydrolysis of a dinucleotide into two mononucleotides. In practical terms, the enzyme uses water to break the bond linking two nucleotide units, releasing each as a free mononucleotide. This activity is also known as dinucleotide nucleotidohydrolase activity, nucleotide diphosphatase activity, or nucleotide pyrophosphatase activity. It is distinct from general phosphatase activity because the substrate is a dinucleotide rather than a simple phosphate ester, and the products are mononucleotides that can enter salvage pathways or serve as signaling molecules.

Why Is dinucleotide phosphatase activity Important in Cell Biology?

Dinucleotide phosphatase activity is important because it sits at the intersection of nucleotide metabolism, redox homeostasis, and cell signaling. By converting dinucleotides to mononucleotides, enzymes with this activity supply substrates for nucleic acid synthesis and energy metabolism, and they also generate or degrade signaling molecules that modulate immune responses. Dysregulation of this activity can alter NAD(H) and NADP(H) pools, affecting cellular antioxidant capacity and biosynthetic reactions. In cancer, changes in nucleotide metabolism support rapid proliferation, and dinucleotide phosphatases may contribute to tumorigenesis by shaping the nucleotide landscape. Therefore, GO:0004551 is a relevant target for mechanistic studies and therapeutic exploration.
Controls the balance of mononucleotides available for DNA and RNA synthesis.
Regulates NAD(H) and NADP(H) homeostasis, impacting redox reactions and biosynthesis.
Modulates purinergic signaling in immune cells through extracellular nucleotide hydrolysis.
Contributes to metabolic reprogramming in cancer, including colorectal tumorigenesis.
Influences inflammatory responses and immune cell activation.
Provides a biochemical link between nucleotide salvage and energy metabolism.
Can be targeted to alter nucleotide pools in disease models.
Serves as a biomarker or therapeutic target in metabolic and inflammatory diseases.
Enables studies of enzyme kinetics and substrate specificity using recombinant proteins.
Supports CRISPR-based functional genomics to identify novel dinucleotide phosphatases.

What Happens During dinucleotide phosphatase activity?

Substrate recognition and binding
In simple terms: The enzyme first grabs the dinucleotide substrate.
Dinucleotide phosphatases recognize their substrates through a binding pocket that accommodates two nucleotide moieties. The binding is often mediated by conserved residues that coordinate the phosphate groups and the ribose rings. For ectoenzymes such as ENPP1, the active site is exposed to the extracellular space, allowing hydrolysis of extracellular dinucleotides. This step ensures specificity for dinucleotides over mononucleotides or other phosphate esters.
Hydrolytic cleavage
In simple terms: Water is used to split the dinucleotide into two mononucleotides.
The catalytic mechanism involves nucleophilic attack by a water molecule on the phosphorus atom, leading to cleavage of the phosphodiester or pyrophosphate bond. This reaction releases two mononucleotides and consumes one water molecule, as defined by GO:0004551. Metal ions such as zinc or magnesium may stabilize the transition state in some enzymes, although the exact cofactor requirements vary among family members.
Product release and downstream metabolism
In simple terms: The mononucleotides are released and enter other metabolic pathways.
After cleavage, the mononucleotide products are released from the active site. These products can be salvaged into nucleotide pools, used for energy transfer, or act as signaling molecules. For example, hydrolysis of extracellular dinucleotides can generate adenosine or other purinergic ligands that modulate immune cell function. Intracellularly, mononucleotides feed into pathways that maintain NAD(H) and NADP(H) balance.
Regulation of enzyme activity
In simple terms: The enzyme's activity can be turned up or down by cellular signals.
Dinucleotide phosphatase activity is regulated at multiple levels, including gene expression, post-translational modifications, and availability of substrates and cofactors. In immune cells, solute carrier transporters can influence the supply of nucleotides and thereby affect enzyme activity. Metabolic signals such as NAD(H) levels can also feedback on nucleotide metabolism. These regulatory layers ensure that dinucleotide hydrolysis is matched to cellular demand.

Key Genes Involved in GO:0004551 dinucleotide phosphatase activity

The following genes encode enzymes or transporters that are functionally linked to dinucleotide phosphatase activity (GO:0004551) or its metabolic context.
GeneMajor RoleResearch Relevance
ENPP1Ectonucleotide pyrophosphatase/phosphodiesterase 1; hydrolyzes extracellular dinucleotidesInvolved in purinergic signaling, immune regulation, and cancer
ENPP3Ectonucleotide pyrophosphatase/phosphodiesterase 3; hydrolyzes nucleotidesStudied in allergic and inflammatory responses
NT5EEcto-5'-nucleotidase (CD73); generates adenosine from AMPLinked to immune suppression and tumor microenvironment
SLC29A1Equilibrative nucleoside transporter 1; regulates nucleotide availabilityModulates immune cell metabolism and drug response
SLC29A2Equilibrative nucleoside transporter 2; transports nucleosidesAffects nucleotide salvage and immune function
ME1Malic enzyme 1; links NADPH production to lipid metabolismRelevant to colorectal tumorigenesis and redox balance
DNMT1DNA methyltransferase 1; maintains DNA methylationEpigenetic regulator in polycystic kidney disease
NRBF2PI3KC3 complex subunit; involved in autophagy and apoptotic cell clearanceModulates intestinal inflammation
NAMPTNicotinamide phosphoribosyltransferase; NAD biosynthesisRegulates NAD(H) homeostasis
NMNAT1Nicotinamide mononucleotide adenylyltransferase 1; NAD synthesisMaintains NAD pools
NADSYN1NAD synthetase 1; converts NAD+ precursorsInvolved in NAD(H) regulation
G6PDGlucose-6-phosphate dehydrogenase; generates NADPHLinks pentose phosphate pathway to redox balance
IDH1Isocitrate dehydrogenase 1; produces NADPHMetabolic enzyme relevant to cancer
IDH2Isocitrate dehydrogenase 2; produces NADPHMitochondrial redox regulation
SLC7A11Cystine/glutamate antiporter; supports glutathione synthesisModulates redox and immune responses
GCLCGlutamate-cysteine ligase catalytic subunit; glutathione synthesisAffects cellular antioxidant capacity
GCLMGlutamate-cysteine ligase modifier subunit; glutathione synthesisRegulates redox homeostasis
TXNThioredoxin; antioxidant proteinMaintains redox balance

How Is dinucleotide phosphatase activity Regulated?

Dinucleotide phosphatase activity is regulated by substrate availability, gene expression, and post-translational modifications. Solute carrier transporters control the intracellular and extracellular concentrations of nucleotides and nucleosides, thereby influencing the flux through dinucleotide phosphatases. NAD(H) and NADP(H) levels can feedback on nucleotide metabolism, as these cofactors are both products and regulators of redox reactions. In immune cells, inflammatory signals can alter the expression of ectonucleotidases, changing the balance of purinergic signaling. Additionally, metabolic enzymes such as ME1 can influence NADPH pools that indirectly affect nucleotide metabolism.

dinucleotide phosphatase activity and Human Disease

GeneDisease / BiologyPotential Experimental Model
ENPP1Cancer, inflammation, purinergic signalingKnockout and overexpression in cancer cell lines
ME1Colorectal tumorigenesis, lipid metabolismPoint-mutation and knockout in colorectal cancer models
DNMT1Autosomal dominant polycystic kidney diseaseKnock-in and knockout in kidney organoids
NRBF2Intestinal inflammation, autophagyKnockout in intestinal epithelial cells
NAMPTNAD(H) homeostasis, metabolic disordersOverexpression and knockout in metabolic cell models
Cancer and metabolic reprogramming
Altered nucleotide metabolism is a hallmark of cancer. Dinucleotide phosphatase activity can contribute to the supply of mononucleotides required for rapid proliferation. In colorectal cancer, the metabolic enzyme ME1 is phosphorylated and acetylated, affecting lipid metabolism and tumorigenesis, which is linked to NADPH and nucleotide balance. Targeting dinucleotide phosphatases may therefore disrupt nucleotide pools essential for tumor growth.
Inflammation and immune regulation
Extracellular dinucleotide phosphatases such as ENPP1 and ENPP3 modulate purinergic signaling, which is critical for immune cell activation and inflammation. Solute carrier transporters that regulate nucleotide availability are metabolic gatekeepers of immune cells. Dysregulation of these pathways can lead to chronic inflammation and autoimmune conditions. NRBF2, a component of the PI3KC3 complex, is required for apoptotic cell clearance and restricts intestinal inflammation, highlighting the interplay between nucleotide metabolism and inflammatory control.
Metabolic and kidney disorders
NAD(H) and NADP(H) homeostasis is essential for cellular function, and its disruption is linked to metabolic disorders. DNMT1 promotes cyst growth and epigenetic age acceleration in autosomal dominant polycystic kidney disease, indicating that epigenetic and metabolic pathways intersect in kidney disease. Dinucleotide phosphatase activity may influence these processes by altering nucleotide availability for methylation reactions.

From dinucleotide phosphatase activity-Related Genes to Experimental Models

Research QuestionSuitable Model
Does loss of ENPP1 alter nucleotide pools?CRISPR knockout in immune or cancer cell lines
Does a point mutation in the catalytic site abolish dinucleotide phosphatase activity?Point-mutation knock-in using CRISPR
Can overexpression of ME1 drive tumorigenesis?Overexpression in colorectal cancer cells
Does tagging endogenous ENPP1 affect its localization?Tagged knock-in with fluorescent protein
Is NRBF2 required for apoptotic cell clearance?Knockout in macrophages
Does DNMT1 mutation affect cyst growth?Knock-in in kidney organoids

How to Study the dinucleotide phosphatase activity Process

MethodWhat It MeasuresTypical Application
Enzyme activity assayHydrolysis of dinucleotide to mononucleotidesKinetic characterization of recombinant enzymes
LC-MS/MS metabolomicsNucleotide and NAD(H) levelsProfiling metabolic changes in knockout cells
CRISPR knockout screenGene essentiality and pathway dependenciesIdentifying regulators of nucleotide metabolism
RNA-seqTranscriptional changesAssessing gene expression after perturbation
Western blotProtein expression and modificationsValidating knockout or overexpression
ImmunofluorescenceSubcellular localizationStudying ectoenzyme trafficking
Bioinformatics pathway analysisEnrichment of metabolic pathwaysInterpreting omics data
In vivo tumor modelsTumor growth and metastasisTesting dinucleotide phosphatase inhibitors
Enzymatic activity assays
Dinucleotide phosphatase activity can be measured using purified recombinant enzymes or cell lysates with synthetic dinucleotide substrates. The release of mononucleotides is typically quantified by HPLC, mass spectrometry, or colorimetric assays. These methods allow determination of kinetic parameters such as Km and Vmax, and can be used to test inhibitors.
Metabolomics and nucleotide profiling
Targeted metabolomics using LC-MS/MS can quantify nucleotide pools in cells and tissues. This approach reveals how genetic perturbations of dinucleotide phosphatases affect NAD(H), NADP(H), and other mononucleotides. Metabolomic profiling is also useful for studying metabolic reprogramming in cancer models.
CRISPR screening and functional genomics
CRISPR knockout libraries can be used to identify genes that modulate dinucleotide phosphatase activity or nucleotide metabolism. For example, screens in immune cells can uncover transporters and enzymes that regulate nucleotide availability. Bioinformatics analysis of screening data helps prioritize candidate genes for follow-up.
Imaging and subcellular localization
Fluorescent tagging of dinucleotide phosphatases enables visualization of their subcellular localization and trafficking. This is particularly relevant for ectoenzymes such as ENPP1, which act at the cell surface. Live-cell imaging can reveal dynamic changes in enzyme distribution under metabolic stress.

How CRISPR Can Be Used to Study GO:0004551 dinucleotide phosphatase activity

Knockout

CRISPR knockout of genes encoding dinucleotide phosphatases, such as ENPP1 or ENPP3, can abolish enzyme activity and reveal its contribution to nucleotide pools and cellular phenotypes. Knockout models are valuable for studying loss-of-function effects in cancer and immune cells.

Point Mutation

Point mutations in catalytic residues can selectively eliminate dinucleotide phosphatase activity without affecting protein expression or scaffolding functions. This approach helps distinguish enzymatic activity from other roles of the protein.

Knock-in

Knock-in of disease-associated mutations or tagged versions of dinucleotide phosphatases allows study of mutant behavior and localization. For example, tagging endogenous ENPP1 with a fluorescent protein enables real-time imaging.

Overexpression

Overexpression of dinucleotide phosphatases can mimic gain-of-function states observed in cancer or metabolic disorders. This is useful for testing whether increased activity drives phenotypic changes such as enhanced proliferation.

How EDITGENE Supports dinucleotide phosphatase activity Research

Researchers studying dinucleotide phosphatase activity-related genes often need to determine whether a candidate gene is causally involved in nucleotide metabolism, immune regulation, or disease progression. EDITGENE provides CRISPR-based cell model services to enable precise genetic perturbations and functional validation.
Contact EDITGENE today to design your custom CRISPR model for dinucleotide phosphatase activity research.

Frequently Asked Questions About dinucleotide phosphatase activity

Dinucleotide phosphatase activity (GO:0004551) is a molecular function that catalyzes the hydrolysis of a dinucleotide into two mononucleotides, as defined by the reaction: a dinucleotide + H2O = 2 mononucleotides.
Genes encoding ectonucleotide pyrophosphatase/phosphodiesterase family members such as ENPP1 and ENPP3, as well as other nucleotide hydrolases, are involved in this activity.
The Gene Ontology ID for dinucleotide phosphatase activity is GO:0004551.
Synonyms include dinucleotide nucleotidohydrolase activity, nucleotide diphosphatase activity, and nucleotide pyrophosphatase activity.
It is measured using enzymatic assays with synthetic dinucleotide substrates, often coupled with HPLC or mass spectrometry to quantify mononucleotide products.
It has been linked to cancer, inflammation, immune dysfunction, and metabolic disorders through its role in nucleotide metabolism and signaling.
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models allow precise perturbation of genes encoding these enzymes.
The reaction is: a dinucleotide + H2O = 2 mononucleotides, which is the definition of GO:0004551.
Pathways involving nucleotide salvage, NAD(H) and NADP(H) homeostasis, and purinergic signaling depend on this activity.
It modulates purinergic signaling by hydrolyzing extracellular dinucleotides, thereby influencing immune cell activation and inflammation.

Conclusion

Dinucleotide phosphatase activity (GO:0004551) is a fundamental molecular function that converts dinucleotides into mononucleotides, impacting nucleotide salvage, redox balance, and cell signaling. Its role in cancer, inflammation, and metabolic disorders makes it a compelling target for mechanistic and therapeutic research. CRISPR-based models provide powerful tools to dissect the causal roles of individual dinucleotide phosphatases and to validate them as drug targets. Future studies integrating metabolomics, functional genomics, and disease models will further illuminate the biology of GO:0004551.

References

  1. 1. Tang G et al.. 2021. Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management.. Acta Pharm Sin B 11(9):2749-2767 PMID: 34589395
  2. 2. Song W et al.. 2020. Solute carrier transporters: the metabolic gatekeepers of immune cells.. Acta Pharm Sin B 10(1):61-78 PMID: 31993307
  3. 3. Wu MY et al.. 2021. PI3KC3 complex subunit NRBF2 is required for apoptotic cell clearance to restrict intestinal inflammation.. Autophagy 17(5):1096-1111 PMID: 32160108
  4. 6. Zhu Y et al.. 2020. Dynamic Regulation of ME1 Phosphorylation and Acetylation Affects Lipid Metabolism and Colorectal Tumorigenesis.. Mol Cell 77(1):138-149.e5 PMID: 31735643
  5. 7. Zhou JX et al.. 2024. DNA methyltransferase 1 (DNMT1) promotes cyst growth and epigenetic age acceleration in autosomal dominant polycystic kidney disease.. Kidney Int 106(2):258-272 PMID: 38782200
  6. 8. Chen L et al.. 2024. Homeostatic regulation of NAD(H) and NADP(H) in cells.. Genes Dis 11(5):101146 PMID: 38988322
Contact Us
*
*
*
*
How did you hear about us: